HPLC

The company registered its Prelude LX-4 MD HPLC as a Class I medical device for general clinical use. 

NEW YORK (GenomeWeb News) – Waters today reported that its revenues in the first quarter were up 2 percent year over year, driven by a resurgence in instrument sales, particularly mass spectrometers.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said today that two of its facilities have achieved ISO 13485 certification, moving the company forward in its efforts to develop liquid chromatography-mass spectrometry systems for clinical use.

NEW YORK (GenomeWeb News) – Shimadzu recently announced the creation of a wholly owned sales company in Taiwan to increase its presence there.

NEW YORK (GenomeWeb News) – Agilent Technologies today announced it has purchased supercritical fluid chromatography company Aurora SFC Systems for an undisclosed amount.
Agilent has acquired Aurora's product line and its IP as part of the deal.

Several mass spec vendors presented this week at the UBS Global Life Sciences Conference in New York City, offering information on various aspects of their businesses, including portions of their proteomics portfolios.

The company, which is currently being acquired by Thermo Fisher Scientific, recorded a 21-percent rise in HPLC sales driven largely by strong demand in China, said CEO Frank Whitney.

With executives from Agilent, Thermo Fisher, Waters, and Danaher presenting this week at the JP Morgan Healthcare Conference, UPLC as well as triple quadrupole and qual-quan mass spec proved primary areas of discussion.

The release of a long-awaited protein biomarker test, increased adoption of a major instrument platform, and a pair of proteome mapping milestones marked a year in which several much-anticipated advances in proteomics arrived.

The platform will be based on Agilent's HPLC-chip technology and will enable high-throughput, nanoscale analysis of N-glycosylated proteins, said a researcher at Dublin's National Institute for Bioprocessing Research and Training.

Pages

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.